{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:46:36Z","timestamp":1787010396327,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:p>A strong interplay exists between sleep and dietary habits, and sleep disturbances have been repeatedly documented in individuals with eating disorders (EDs). The orexin system \u2013 implicated in sleep regulation, energy homeostasis, and food reward - may represent a mechanist link between sleep alterations and disordered eating behaviors. Daridorexant is a dual orexin receptor antagonist (DORA) recently approved for the treatment of insomnia, with demonstrated efficacy and tolerability. Owing to its action on orexin neurons, the compound represents an intriguing option for addressing both sleep-related and core symptoms of EDs. By inhibiting motor hyperactivity, daridorexant may reduce excessive physical exercise in individuals with anorexia nervosa (AN) restricting type. Additionally, the compound may exert anti-binge effects, suggesting broad applicability in binge ED, bulimia nervosa, and binge\/purging AN. In this framework, daridorexant emerges as a promising therapeutic option, offering a multifaceted approach to improving circadian rhythms, energy balance, and overall quality of life in individuals with diverse ED subtypes.<\/jats:p>","DOI":"10.1097\/yic.0000000000000552","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T14:00:17Z","timestamp":1715263217000},"page":"115-118","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["The potential use of daridorexant in eating disorders: beyond the treatment of insomnia?"],"prefix":"10.1097","volume":"40","author":[{"given":"Alice","family":"Caldiroli","sequence":"first","affiliation":[{"name":"Department of Mental Health, Fondazione IRCCS San Gerardo dei Tintori"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia M.","family":"Affaticati","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Milan Bicocca, Monza (MB)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Capuzzi","sequence":"additional","affiliation":[{"name":"Department of Mental Health, Fondazione IRCCS San Gerardo dei Tintori"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"La Tegola","sequence":"additional","affiliation":[{"name":"Department of Mental Health, Fondazione IRCCS San Gerardo dei Tintori"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizia","family":"Colmegna","sequence":"additional","affiliation":[{"name":"Department of Mental Health, Fondazione IRCCS San Gerardo dei Tintori"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Clerici","sequence":"additional","affiliation":[{"name":"Department of Mental Health, Fondazione IRCCS San Gerardo dei Tintori"},{"name":"Department of Medicine and Surgery, University of Milan Bicocca, Monza (MB)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonios","family":"Dakanalis","sequence":"additional","affiliation":[{"name":"Department of Mental Health, Fondazione IRCCS San Gerardo dei Tintori"},{"name":"Department of Medicine and Surgery, University of Milan Bicocca, Monza (MB)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Buoli","sequence":"additional","affiliation":[{"name":"Department of Neurosciences and Mental Health, Fondazione IRCCS Ca\u2019Granda Ospedale Maggiore Policlinico"},{"name":"Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,5,10]]},"reference":[{"key":"R1-20250131","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11920-016-0728-8","article-title":"Sleep and eating disorders.","volume":"18","author":"Allison","year":"2016","journal-title":"Curr Psychiatry Rep"},{"key":"R2-20250131","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.sleep.2018.03.032","article-title":"Sleep profile in anorexia and bulimia nervosa female patients.","volume":"48","author":"Asaad Abdou","year":"2018","journal-title":"Sleep Med"},{"key":"R3-20250131","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/bs.irn.2017.06.006","article-title":"Orexin\/hypocretin system: role in food and drug overconsumption.","volume":"136","author":"Barson","year":"2017","journal-title":"Int Rev Neurobiol"},{"key":"R4-20250131","doi-asserted-by":"crossref","first-page":"110320","DOI":"10.1016\/j.mce.2018.10.018","article-title":"Neuroendocrinology of reward in anorexia nervosa and bulimia nervosa: Beyond leptin and ghrelin.","volume":"497","author":"Berner","year":"2019","journal-title":"Mol Cell Endocrinol"},{"key":"R5-20250131","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1002\/cmdc.202000453","article-title":"The quest for the best dual orexin receptor antagonist (daridorexant) for the treatment of insomnia disorders.","volume":"15","author":"Boss","year":"2020","journal-title":"ChemMedChem"},{"key":"R6-20250131","doi-asserted-by":"crossref","first-page":"109815","DOI":"10.1016\/j.neuropharm.2023.109815","article-title":"Clinical usefulness of dual orexin receptor antagonism beyond insomnia: Neurological and psychiatric comorbidities.","volume":"245","author":"Carpi","year":"2024","journal-title":"Neuropharmacology"},{"key":"R7-20250131","doi-asserted-by":"crossref","first-page":"65","DOI":"10.17241\/smr.2020.00780","article-title":"Sleep-related eating disorder and nocturnal eating syndrome.","volume":"11","author":"Cho","year":"2020","journal-title":"Sleep Med Res"},{"key":"R8-20250131","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/erv.2587","article-title":"An examination of the relationship between binge eating disorder and insomnia symptoms.","volume":"26","author":"Kenny","year":"2018","journal-title":"Eur Eat Disord Rev"},{"key":"R10-20250131","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s40263-022-00980-8","article-title":"Long-Term Safety and Tolerability of Daridorexant in Patients with Insomnia Disorder.","volume":"37","author":"Kunz","year":"2023","journal-title":"CNS Drugs"},{"key":"R12-20250131","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s40265-022-01699-y","article-title":"Daridorexant: first approval.","volume":"82","author":"Markham","year":"2022","journal-title":"Drugs"},{"key":"R13-20250131","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1038\/s41386-021-01052-z","article-title":"Sleep dysregulation in binge eating disorder and \u2018food addiction\u2019: the orexin (hypocretin) system as a potential neurobiological link.","volume":"46","author":"Mehr","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"R14-20250131","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1474-4422(21)00436-1","article-title":"Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials.","volume":"21","author":"Mignot","year":"2022","journal-title":"Lancet Neurol"},{"key":"R15-20250131","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.2147\/DMSO.S257687","article-title":"Aerobic exercise and metabolic syndrome: the role of sympathetic activity and the redox system.","volume":"13","author":"Monda","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"R16-20250131","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.pbb.2010.06.013","article-title":"Increased orexin and melanin-concentrating hormone expression in the perifornical lateral hypothalamus of rats prone to overconsuming a fat-rich diet.","volume":"96","author":"Morganstern","year":"2010","journal-title":"Pharmacol Biochem Behav"},{"key":"R17-20250131","doi-asserted-by":"crossref","first-page":"e13902","DOI":"10.1111\/jsr.13902","article-title":"The orexin story and orexin receptor antagonists for the treatment of insomnia.","volume":"32","author":"Muehlan","year":"2023","journal-title":"J Sleep Res"},{"key":"R18-20250131","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1038\/npp.2012.48","article-title":"Role of orexin-1 receptor mechanisms on compulsive food consumption in a model of binge eating in female rats.","volume":"37","author":"Piccoli","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"R19-20250131","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jad.2021.06.061","article-title":"Pinpointing core and pathway symptoms among sleep disturbance, anxiety, worry, and eating disorder symptoms in anorexia nervosa and atypical anorexia nervosa.","volume":"294","author":"Ralph-Nearman","year":"2021","journal-title":"J Affect Disord"},{"key":"R20-20250131","first-page":"256","article-title":"Daridorexant, a recently approved dual orexin receptor antagonists (DORA) in treatment of insomnia.","volume":"16","author":"Sarathi Chakraborty","year":"2023","journal-title":"Sleep science (Sao Paulo, Brazil)"},{"key":"R21-20250131","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.psyneuen.2015.12.014","article-title":"Orexin and sleep quality in anorexia nervosa: clinical relevance and influence on treatment outcome.","volume":"65","author":"Sauchelli","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"R22-20250131","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.neuron.2017.01.014","article-title":"Neural circuitry of wakefulness and sleep.","volume":"93","author":"Scammell","year":"2017","journal-title":"Neuron"},{"key":"R23-20250131","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000514960","article-title":"Sleep, orexin and cognition.","volume":"45","author":"Toor","year":"2021","journal-title":"Front Neurol Neurosci"},{"key":"R24-20250131","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0896-6273(03)00330-1","article-title":"Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes.","volume":"38","author":"Willie","year":"2003","journal-title":"Neuron"},{"key":"R25-20250131","doi-asserted-by":"crossref","first-page":"e34206","DOI":"10.1097\/MD.0000000000034206","article-title":"A review of physiological functions of orexin: From instinctive responses to subjective cognition.","volume":"102","author":"Xia","year":"2023","journal-title":"Medicine (Baltimore)"}],"container-title":["International Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/YIC.0000000000000552","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T06:00:47Z","timestamp":1738303247000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/YIC.0000000000000552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,10]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/yic.0000000000000552","relation":{},"ISSN":["0268-1315","1473-5857"],"issn-type":[{"value":"0268-1315","type":"print"},{"value":"1473-5857","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,10]]}}}